Richter-Helm Biologics, Gedeon Richter Plc. ("Richter") and Helm AG's joint venture microbial biotechnology contract development and cGMP manufacturing organization, today…
Gedeon Richter Plc. ("Richter") today announced that it has entered into an asset purchase agreement with Mycenax Biotech Inc. ("Mycenax")…
Gedeon Richter Plc. ("Richter") today announced that it has launched its biosimilar teriparatide, Terrosa® in Europe. The product is approved…